Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ahmad Hassan Ali, Jennifer Damman, Shamita B. Shah, Yinka Davies, Melissa Hurwitz, Mariam Stephen, Leta M. Lemos, Elizabeth J. Carey, Keith D. Lindor, Cynthia W. Buness, Leina Alrabadi, William E. Berquist & Kenneth L. Cox. (2020) Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 55:8, pages 941-950.
Read now
Read now
Amir Kalani, James H. Tabibian & Keith D. Lindor. (2018) Emerging therapeutic targets for primary sclerosing cholangitis. Expert Opinion on Orphan Drugs 6:7, pages 393-401.
Read now
Read now
Sabrina Cardile, Tommaso Alterio, Manila Candusso, Andrea Pietrobattista, Daniela Liccardo, Maria Sole Basso, Bronislava Papadatou, Fiammetta Bracci, Daniela Knafelz & Giuliano Torre. (2017) Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives. Scandinavian Journal of Gastroenterology 52:6-7, pages 662-667.
Read now
Read now
Eduardo A. Rodriguez, Elizabeth J. Carey & Keith D. Lindor. (2017) Emerging treatments for primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 11:5, pages 451-459.
Read now
Read now
Veena L Venkat, Sarangarajan Ranganathan & Rakesh Sindhi. (2015) The challenges of liver transplantation in children with primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 9:3, pages 289-294.
Read now
Read now
Articles from other publishers (58)
Yoh Zen, Stefan G. Hübscher & Yasuni Nakanuma. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
556
643
.
Federica Del Chierico, Sabrina Cardile, Valerio Baldelli, Tommaso Alterio, Sofia Reddel, Matteo Bramuzzo, Daniela Knafelz, Sara Lega, Fiammetta Bracci, Giuliano Torre, Giuseppe Maggiore & Lorenza Putignani. (2023) Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. Inflammatory Bowel Diseases.
Crossref
Crossref
Anabel Martinez Lyons & Luke Boulter. (2023) NOTCH signalling – a core regulator of bile duct disease?. Disease Models & Mechanisms 16:9.
Crossref
Crossref
Stephanie L. Rager & Melody Y. Zeng. (2023) The Gut–Liver Axis in Pediatric Liver Health and Disease. Microorganisms 11:3, pages 597.
Crossref
Crossref
Rebecca Little, Binita M. Kamath & Amanda Ricciuto. 2023. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
129
149
.
Li Wang, Zheng-Min Cao, Li-Li Zhang, Juan-mei Li & Wen-liang Lv. (2022) The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. Frontiers in Immunology 13.
Crossref
Crossref
James Gage Buness, Ahmad Hassan Ali, James H. Tabibian, Cynthia W. Buness, Kenneth L. Cox & Keith D. Lindor. (2022) Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series. American Journal of Therapeutics 29:4, pages e437-e443.
Crossref
Crossref
Cynthia W. Buness, Kevin M. Johnson, Ahmad Hassan Ali, Leina Alrabadi, Keith D. Lindor, Tamir Miloh & Kenneth L. Cox. (2020) Successful response of primary sclerosing cholangitis and associated ulcerative colitis to oral vancomycin may depend on brand and personalized dose: report in an adolescent. Clinical Journal of Gastroenterology 14:2, pages 684-689.
Crossref
Crossref
Ramon V. Cortez, Luana N. Moreira, Marina Padilha, Mariana D. Bibas, Ricardo K. Toma, Gilda Porta & Carla R. Taddei. (2021) Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis. Frontiers in Immunology 11.
Crossref
Crossref
Simon D. Goldenberg & Blair Merrick. (2021)
The role of faecal microbiota transplantation: looking beyond
Clostridioides difficile
infection
. Therapeutic Advances in Infectious Disease 8, pages 204993612098152.
Crossref
Crossref
Thijmen Visseren, Gwenny Manel Fuhler, Nicole Stephanie Erler, Yoena Roos Anna Nossent, Herold Johnny Metselaar, Jan Nicolaas Maria IJzermans, Sarwa Darwish Murad & Maikel Petrus Peppelenbosch. (2020) Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant – a pilot study. Transplant International 33:11, pages 1424-1436.
Crossref
Crossref
Chao Yan, Stephane Koda, Jing Wu, Bei‐Bei Zhang, Qian Yu, Mihai G. Netea, Ren‐Xian Tang & Kui‐Yang Zheng. (2020) Roles of Trained Immunity in the Pathogenesis of Cholangiopathies: A Therapeutic Target. Hepatology 72:5, pages 1838-1850.
Crossref
Crossref
Xing Zhou, Muchena J. Kailemia, Ying Sun, Zongwen Shuai, Guo-Xiang Yang, Sandeep Dhaliwal, Laura Cristoferi, Patrick S.C. Leung, Pietro Invernizzi, Christopher L. Bowlus, Carlito B. Lebrilla, Aftab A. Ansari, William M. Ridgway, Weici Zhang & M. Eric Gershwin. (2020) Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis. Journal of Autoimmunity 113, pages 102503.
Crossref
Crossref
Cătălina Vlăduţ, Mihai Ciocîrlan, Dana Bilous, Vasile Șandru, Mădălina Stan-Ilie, Nikola Panic, Gabriel Becheanu, Mariana Jinga, Raluca S. Costache, Daniel O. Costache & Mircea Diculescu. (2020) An Overview on Primary Sclerosing Cholangitis. Journal of Clinical Medicine 9:3, pages 754.
Crossref
Crossref
Daniel A. Kinderlehrer. (2020) Is Bartonella a Cause of Primary Sclerosing Cholangitis? A Case Study. Gastrointestinal Disorders 2:1, pages 48-57.
Crossref
Crossref
Claudio Pinto, Elisabetta Ninfole, Antonio Benedetti, Luca Maroni & Marco Marzioni. (2020) Aging-Related Molecular Pathways in Chronic Cholestatic Conditions. Frontiers in Medicine 6.
Crossref
Crossref
Susan S. Baker & Robert D. Baker. 2020. Gut Microbiota and Pathogenesis of Organ Injury. Gut Microbiota and Pathogenesis of Organ Injury
39
54
.
F Jones & G A Doherty. (2019) Vedolizumab in IBD/PSC: A Case for Careful Vigilance?. Journal of Crohn's and Colitis 13:10, pages 1237-1238.
Crossref
Crossref
Jessica R. Allegretti, Zain Kassam, Madeline Carrellas, Benjamin H. Mullish, Julian R. Marchesi, Alexandros Pechlivanis, Mark Smith, Ylaine Gerardin, Sonia Timberlake, Daniel S. Pratt & Joshua R. Korzenik. (2019) Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial. American Journal of Gastroenterology 114:7, pages 1071-1079.
Crossref
Crossref
Martin Kummen & Johannes R. Hov. (2019) The gut microbial influence on cholestatic liver disease. Liver International 39:7, pages 1186-1196.
Crossref
Crossref
Zhao Peng, Yuxiao Liao, Liangkai Chen, Shuang Liu, Zhilei Shan, Andreas K. Nüssler, Ping Yao, Hong Yan, Liegang Liu & Wei Yang. (2019) Heme oxygenase-1 attenuates low-dose of deoxynivalenol-induced liver inflammation potentially associating with microbiota. Toxicology and Applied Pharmacology 374, pages 20-31.
Crossref
Crossref
Keisaku Sato, Fanyin Meng, Giammarco Fava, Shannon Glaser & Gianfranco Alpini. (2019) Functional roles of gut bacteria imbalance in cholangiopathies. Liver Research 3:1, pages 40-45.
Crossref
Crossref
Chieh‐Chang Chen, Yen‐Nien Chen, Jyh‐Ming Liou & Ming‐Shiang Wu. (2019) From germ theory to germ therapy. The Kaohsiung Journal of Medical Sciences 35:2, pages 73-82.
Crossref
Crossref
Kwang Il SeoSang-Bum Kang. (2019) Hepatobiliary Manifestation of Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 73:5, pages 248.
Crossref
Crossref
Aryashree Arunima, Jugal Kishore Das & Mrutyunjay Suar. 2019. Dietary Interventions in Gastrointestinal Diseases. Dietary Interventions in Gastrointestinal Diseases
117
131
.
Terumi Kamisawa, Takahiro Nakazawa, Susumu Tazuma, Yoh Zen, Atsushi Tanaka, Hirotaka Ohara, Takashi Muraki, Kazuo Inui, Dai Inoue, Takayoshi Nishino, Itaru Naitoh, Takao Itoi, Kenji Notohara, Atsushi Kanno, Kensuke Kubota, Kenji Hirano, Hiroyuki Isayama, Kyoko Shimizu, Toshio Tsuyuguchi, Tooru Shimosegawa, Shigeyuki Kawa, Tsutomu Chiba, Kazuichi Okazaki, Hajime Takikawa, Wataru Kimura, Michiaki Unno & Masahiro Yoshida. (2019) Clinical practice guidelines for IgG4‐related sclerosing cholangitis. Journal of Hepato-Biliary-Pancreatic Sciences 26:1, pages 9-42.
Crossref
Crossref
Jose Melendez-Rosado, Ali Alsaad, Fernando F. Stancampiano & William C. Palmer. (2018) Abnormal Liver Enzymes. Gastroenterology Nursing 41:6, pages 497-507.
Crossref
Crossref
Hiroyuki Isayama, Susumu Tazuma, Norihiro Kokudo, Atsushi Tanaka, Toshio Tsuyuguchi, Takahiro Nakazawa, Kenji Notohara, Suguru Mizuno, Nobuhisa Akamatsu, Masahiro Serikawa, Itaru Naitoh, Yoshiki Hirooka, Toshifumi Wakai, Takao Itoi, Tomoki Ebata, Shinji Okaniwa, Terumi Kamisawa, Hiroki Kawashima, Atsushi Kanno, Keiichi Kubota, Masami Tabata, Michiaki Unno & Hajime Takikawa. (2018) Clinical guidelines for primary sclerosing cholangitis 2017. Journal of Gastroenterology 53:9, pages 1006-1034.
Crossref
Crossref
James H. Tabibian & Christopher L. Bowlus. (2018) WITHDRAWN: Primary sclerosing cholangitis: A review and update. Liver Research.
Crossref
Crossref
Daniel Sprockett, Tadashi Fukami & David A. Relman. (2018) Role of priority effects in the early-life assembly of the gut microbiota. Nature Reviews Gastroenterology & Hepatology 15:4, pages 197-205.
Crossref
Crossref
Mario Strazzabosco, Romina Fiorotto, Massimiliano Cadamuro, Carlo Spirli, Valeria Mariotti, Eleanna Kaffe, Roberto Scirpo & Luca Fabris. (2018) Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:4, pages 1374-1379.
Crossref
Crossref
J Torres, C Palmela, H Brito, X Bao, H Ruiqi, P Moura-Santos, J Pereira da Silva, A Oliveira, C Vieira, K Perez, SH Itzkowitz, JF Colombel, L Humbert, D Rainteau, M Cravo, CM Rodrigues & J Hu. (2017) The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease. United European Gastroenterology Journal 6:1, pages 112-122.
Crossref
Crossref
Yoh Zen, Stefan G. Hübscher & Yasuni Nakanuma. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver
515
593
.
Christopher Bowlus, David N. Assis & David Goldberg. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
626
647.e6
.
Patrick Martin Gillevet & Puneet Puri. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
37
65.e6
.
Amir Houshang Mohammad Alizadeh. (2017) Cholangitis: Diagnosis, Treatment and Prognosis. Journal of Clinical and Translational Hepatology 5:4, pages 1-10.
Crossref
Crossref
James H. Tabibian & Christopher L. Bowlus. (2017) Primary sclerosing cholangitis: A review and update. Liver Research 1:4, pages 221-230.
Crossref
Crossref
Dustin E. Bosch & Matthew M. Yeh. (2017) Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease. Human Pathology 69, pages 55-62.
Crossref
Crossref
You Li, Ruqi Tang, Patrick S.C. Leung, M. Eric Gershwin & Xiong Ma. (2017) Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Autoimmunity Reviews 16:9, pages 885-896.
Crossref
Crossref
Pedro Pereira, Velma Aho, Johanna Arola, Sonja Boyd, Kalle Jokelainen, Lars Paulin, Petri Auvinen & Martti Färkkilä. (2017) Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia. PLOS ONE 12:8, pages e0182924.
Crossref
Crossref
Angela C. Cheung, Konstantinos N. Lazaridis, Nicholas F. LaRusso & Gregory J. Gores. (2017) Emerging pharmacologic therapies for primary sclerosing cholangitis. Current Opinion in Gastroenterology 33:3, pages 149-157.
Crossref
Crossref
Sophie Restellini, Olivier Chazouillères & Jean‐Louis Frossard. (2016) Hepatic manifestations of inflammatory bowel diseases. Liver International 37:4, pages 475-489.
Crossref
Crossref
James H. Tabibian, Konstantinos N. Lazaridis & Nicholas F. LaRusso. 2017. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set
663
674.e5
.
Amanda Ricciuto & Binita M. Kamath. 2017. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
117
134
.
Ahmad H. Ali & Keith D. Lindor. (2016) Novel treatments in primary sclerosing cholangitis. Clinical Liver Disease 8:5, pages 132-135.
Crossref
Crossref
Jennifer L Horsley-Silva, Elizabeth J Carey & Keith D Lindor. (2016) Advances in primary sclerosing cholangitis. The Lancet Gastroenterology & Hepatology 1:1, pages 68-77.
Crossref
Crossref
J. Torres, X. Bao, A. Goel, J.-F. Colombel, J. Pekow, B. Jabri, K.M. Williams, A. Castillo, J.A. Odin, K. Meckel, F. Fasihuddin, I. Peter, S. Itzkowitz & J. Hu. (2016) The features of mucosa-associated microbiota in primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 43:7, pages 790-801.
Crossref
Crossref
Cynthia BunessKeith D. LindorTamir Miloh. (2016) Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis. Pediatric Gastroenterology, Hepatology & Nutrition 19:3, pages 210.
Crossref
Crossref
Sum P. Lee, Joseph R. Roberts & Rahul Kuver. (2016) The changing faces of cholangitis. F1000Research 5, pages 1409.
Crossref
Crossref
Iliana Doycheva, Michael D. Leise & Kymberly D. Watt. (2016) The Intestinal Microbiome and the Liver Transplant Recipient. Transplantation 100:1, pages 61-68.
Crossref
Crossref
Cynthia Levy. (2015) Can we avoid primary sclerosing cholangitis recurrence?. Liver Transplantation 22:1, pages 12-13.
Crossref
Crossref
Hanns‐Ulrich Marschall & Fredrik Bäckhed. (2015) Could gut microbiota protect against sclerosing cholangitis?. Hepatology 63:1, pages 26-27.
Crossref
Crossref
Dermot P.B. McGovern, Subra Kugathasan & Judy H. Cho. (2015) Genetics of Inflammatory Bowel Diseases. Gastroenterology 149:5, pages 1163-1176.e2.
Crossref
Crossref
Seth N Sclair, Ester Little & Cynthia Levy. (2015) Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clinical and Translational Gastroenterology 6:8, pages e109.
Crossref
Crossref
Yasuni Nakanuma, Motoko Sasaki & Kenichi Harada. (2015) Autophagy and senescence in fibrosing cholangiopathies. Journal of Hepatology 62:4, pages 934-945.
Crossref
Crossref
James H. Tabibian, Cyril Varghese, Steven P. O'Hara & Nicholas F. LaRusso. (2015) Microbiome‐immune interactions and liver disease. Clinical Liver Disease 5:4, pages 83-85.
Crossref
Crossref
J. H. Tabibian & K. D. Lindor. (2015) Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease. Alimentary Pharmacology & Therapeutics 41:5, pages 490-490.
Crossref
Crossref
Kai Mao, Wen Jiang, Jieqiong Liu & Jie Wang. (2015) Incidence of Subsequent Cholangiocarcinomas After Another Malignancy. Medicine 94:8, pages e596.
Crossref
Crossref